The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global fetal and neonatal care equipment market size reached US$ 7.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 12.0 Billion by 2027, exhibiting a growth rate (CAGR) of 7.9% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The fetal and neonatal care (FNC) equipment are specialized devices that are used to diagnose, monitor and treat diseases and medical ailments of the fetus and newborn babies. These devices are crucial for routine check-ups in gynecology and obstetrics interventions. Ultrasound devices, fetal dopplers, fetal MRI systems, incubators, phototherapy and respiratory devices are some of the most extensively utilized FNC equipment. They also find applications in the Neonatal Intensive Care Units (NICUs) for the treatment of ailments, including anemia, bronchopulmonary dysplasia, intraventricular hemorrhage, hyperbilirubinemia and transient tachypnea.
The increasing prevalence of hospital-acquired neonatal ailments and complications is one of the key factors driving the growth of the market. Furthermore, the rising cases of premature birth with low immunity and weight are contributing to the increasing requirement of FNC equipment across the globe. Maternal and fetal care is rapidly becoming a global priority to prevent fatalities during pregnancy and childbirth. Additionally, technological advancements and innovations in patient monitoring, respiratory, and phototherapy devices aimed at making them more user-friendly, cost-effective and highly accurate, are providing a boost to the market. Moreover, equipment features such as light-weight, compact designs and remote monitoring facilities are further increasing product adoption in medical institutions. Other factors, including improving fertility rate, efforts by both government and non-government organizations (NGOs) to create awareness for fetal and neonatal care and extensive research and development (R&D), are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global fetal and neonatal care equipment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type and end-user.
Breakup by Product Type:
Breakup by End-User:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being ArjoHuntleigh, Atom Medical Corporation, Becton Dickinson, Covidien, Drägerwerk, Fisher & Paykel, GE Healthcare, Masimo, Medtronic PLC, Natus Medical Incorporated, Philips Healthcare, Phoenix Medical Systems, Smiths Medical, Spacelabs Healthcare, Utah Medical Products and Vyaire Medical Inc., etc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico, Argentina, Colombia, Chile, Peru, Turkey, Saudi Arabia, Iran, United Arab Emirates|
|Companies Covered||ArjoHuntleigh, Atom Medical Corporation, Becton Dickinson, Covidien, Drägerwerk, Fisher & Paykel, GE Healthcare, Masimo, Medtronic PLC, Natus Medical Incorporated, Philips Healthcare, Phoenix Medical Systems, Smiths Medical, Spacelabs Healthcare, Utah Medical Products and Vyaire Medical Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
The global fetal and neonatal care equipment market was valued at US$ 7.7 Billion in 2021.
We expect the global fetal and neonatal care equipment market to exhibit a CAGR of 7.9% during 2022-2027.
The rising cases of premature birth and neonatal complications, along with the growing demand for FNC equipment to diagnose, monitor, and treat the fetus and newborn babies, are primarily driving the global fetal and neonatal care equipment market.
The sudden outbreak of the COVID-19 pandemic has led to the rising demand for fetal and neonatal care equipment to treat pregnant women, lactating mothers, and newborn babies owing to their high susceptibility to the coronavirus disease.
Based on the product type, the global fetal and neonatal care equipment market has been segregated into NICU equipment, fetal care equipment & neonatal care equipment, and others. Among these, NICU equipment, including neonatal monitoring devices, currently account for the majority of the global market share.
Based on the end user, the global fetal and neonatal care equipment market can be bifurcated into hospitals, diagnostic centers, clinics, and others. Currently, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global fetal and neonatal care equipment market include ArjoHuntleigh, Atom Medical Corporation, Becton Dickinson, Covidien, Drägerwerk, Fisher & Paykel, GE Healthcare, Masimo, Medtronic PLC, Natus Medical Incorporated, Philips Healthcare, Phoenix Medical Systems, Smiths Medical, Spacelabs Healthcare, Utah Medical Products, Vyaire Medical Inc., etc.
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2023-2028
Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Urology Robotic Surgery Market by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at